Association between pazopanib exposure and safety in Japanese patients with renal cell carcinoma or soft tissue sarcoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Association between pazopanib exposure and safety in Japanese patients with renal cell carcinoma or soft tissue sarcoma ; volume:13 ; number:1 ; day:6 ; month:2 ; year:2023 ; pages:1-9 ; date:12.2023
Scientific reports ; 13, Heft 1 (6.2.2023), 1-9, 12.2023
- Urheber
-
Aoyama, Takeshi
Nakano, Kenji
Yuasa, Takeshi
Sugiyama, Erika
Okawa, Takako
Ito, Kazuyuki
Azuma, Keiichi
Hashimoto, Koki
Furutani, Ryota
Hiraide, Makoto
Kobayashi, Kazuo
Suzuki, Kenichi
Tomomatsu, Jyunnichi
Tajima, Masataka
Sato, Hitoshi
Hama, Toshihiro
Takahashi, Shunji
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-023-28688-9
- URN
-
urn:nbn:de:101:1-2023041021114166846970
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Aoyama, Takeshi
- Nakano, Kenji
- Yuasa, Takeshi
- Sugiyama, Erika
- Okawa, Takako
- Ito, Kazuyuki
- Azuma, Keiichi
- Hashimoto, Koki
- Furutani, Ryota
- Hiraide, Makoto
- Kobayashi, Kazuo
- Suzuki, Kenichi
- Tomomatsu, Jyunnichi
- Tajima, Masataka
- Sato, Hitoshi
- Hama, Toshihiro
- Takahashi, Shunji
- SpringerLink (Online service)
Ähnliche Objekte (12)
Exposure-survival analyses of pazopanib in renal cell carcinoma and soft tissue sarcoma patients: opportunities for dose optimization
Disease Response to Pazopanib in Follicular Dendritic Cell Sarcoma
Pazopanib-induced enteritis in a patient with renal cell carcinoma
Long-Term Control of Metastatic Renal Cell Carcinoma Using Pazopanib
Harnessing soft tissue sarcoma with low-dose pazopanib – a matter of blood levels
PD-L1 tumour expression is predictive of pazopanib response in soft tissue sarcoma
Secondary spontaneous pneumothorax in patients with sarcoma treated with Pazopanib, a case control study
Real-world data on the management of pazopanib-induced liver toxicity in routine care of renal cell cancer and soft tissue sarcoma patients
Safety and efficacy of Pazopanib in advanced soft tissue sarcoma: PALETTE (EORTC 62072) subgroup analyses
Reversible Hypopigmentation with Pazopanib
Good and sustained response to pembrolizumab and pazopanib in advanced undifferentiated pleomorphic sarcoma: a case report
Systemic Therapy for Soft Tissue Sarcoma: Proposals for the Optimal Use of Pazopanib, Trabectedin, and Eribulin
Exposure-survival analyses of pazopanib in renal cell carcinoma and soft tissue sarcoma patients: opportunities for dose optimization
Disease Response to Pazopanib in Follicular Dendritic Cell Sarcoma
Pazopanib-induced enteritis in a patient with renal cell carcinoma
Long-Term Control of Metastatic Renal Cell Carcinoma Using Pazopanib
Harnessing soft tissue sarcoma with low-dose pazopanib – a matter of blood levels
PD-L1 tumour expression is predictive of pazopanib response in soft tissue sarcoma
Secondary spontaneous pneumothorax in patients with sarcoma treated with Pazopanib, a case control study
Real-world data on the management of pazopanib-induced liver toxicity in routine care of renal cell cancer and soft tissue sarcoma patients
Safety and efficacy of Pazopanib in advanced soft tissue sarcoma: PALETTE (EORTC 62072) subgroup analyses
Reversible Hypopigmentation with Pazopanib
Good and sustained response to pembrolizumab and pazopanib in advanced undifferentiated pleomorphic sarcoma: a case report
Systemic Therapy for Soft Tissue Sarcoma: Proposals for the Optimal Use of Pazopanib, Trabectedin, and Eribulin
Exposure-survival analyses of pazopanib in renal cell carcinoma and soft tissue sarcoma patients: opportunities for dose optimization
Disease Response to Pazopanib in Follicular Dendritic Cell Sarcoma
Pazopanib-induced enteritis in a patient with renal cell carcinoma
Long-Term Control of Metastatic Renal Cell Carcinoma Using Pazopanib
Harnessing soft tissue sarcoma with low-dose pazopanib – a matter of blood levels
PD-L1 tumour expression is predictive of pazopanib response in soft tissue sarcoma
Secondary spontaneous pneumothorax in patients with sarcoma treated with Pazopanib, a case control study
Real-world data on the management of pazopanib-induced liver toxicity in routine care of renal cell cancer and soft tissue sarcoma patients
Safety and efficacy of Pazopanib in advanced soft tissue sarcoma: PALETTE (EORTC 62072) subgroup analyses
Reversible Hypopigmentation with Pazopanib
Good and sustained response to pembrolizumab and pazopanib in advanced undifferentiated pleomorphic sarcoma: a case report